ERCC1 as a predictor of response to induction therapy for stage III non-small cell lung cancer.

被引：0
|
作者：
Marra, Alessandro
Kemming, Dirk
Krueer, Thomas
Bosse, Ulrich
Netchaeva, Maria
Wagner, Wolfgang
Koch, Olaf M.
Vogt, Ulf
Hillejan, Ludger
机构：
[1] Niels Stensen Clin, Lung Ctr, Ostercappeln, Germany
[2] European Lab Assoc, Ibbenburen, Germany
[3] Inst Pathol Osnabruck, Osnabruck, Germany
[4] Klinikum Osnabruck, Osnabruck, Germany
[5] Paracelsus Klin, Dept Radiooncol, Osnabruck, Germany
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2013年 / 31卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e18511
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Prognostic potential of ERCC1 protein expression and clinicopathologic factors in stage III/N2 non-small cell lung cancer
    Yan, Dong
    Wei, Ping
    An, Guangyu
    Chen, Wenming
    JOURNAL OF CARDIOTHORACIC SURGERY, 2013, 8
  • [22] Role of Surgery Following Induction Therapy for Stage III Non-Small Cell Lung Cancer
    Daly, Benedict D. T.
    Cerfolio, Robert J.
    Krasna, Mark J.
    SURGICAL ONCOLOGY CLINICS OF NORTH AMERICA, 2011, 20 (04) : 721 - +
  • [23] Expression of ERCC1 and class III β-tubulin in non-small cell lung cancer patients treated with carboplatin and paclitaxel
    Azuma, Koichi
    Sasada, Tetsuro
    Kawahara, Akihiko
    Takamori, Sinzo
    Hattori, Satoshi
    Ikeda, Jiro
    Itoh, Kyogo
    Yamada, Akira
    Kage, Masayoshi
    Kuwano, Michihiko
    Aizawa, Hisamichi
    LUNG CANCER, 2009, 64 (03) : 326 - 333
  • [24] ERCC1 EXPRESSION TESTING IN STAGE I NON-SMALL CELL LUNG CANCER: POTENTIAL CLINICAL AND ECONOMIC OUTCOMES
    Roth, J.
    Carlson, J. J.
    Veenstra, D.
    VALUE IN HEALTH, 2011, 14 (03) : A166 - A166
  • [25] ERCC1 expression by immunohistochemistry and EGFR mutations in resected non-small cell lung cancer
    Lee, Kyung-Hun
    Min, Hye Sook
    Han, Sae-Won
    Oh, Do-Youn
    Lee, Se-Hoon
    Kim, Dong-Wan
    Im, Seock-Ah
    Chung, Doo Hyun
    Kim, Young Tale
    Kim, Tae-You
    Heo, Dae Seog
    Bang, Yung-Jue
    Sung, Sook Whan
    Kim, Joo Hyun
    LUNG CANCER, 2008, 60 (03) : 401 - 407
  • [26] THE VALUE OF CLINICAL TRIAL RESEARCH FOR ERCC1 TESTING IN STAGE I NON-SMALL CELL LUNG CANCER (NSCLC)
    Roth, Joshua A.
    Carlson, Josh J.
    Steuten, Lotte
    Ramsey, Scott D.
    Veenstra, David L.
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S398 - S399
  • [27] Prognostic value of ERCC1 expression in advanced non-small cell lung cancer (NSCLC)
    Kollmeier, Jens
    Blum, Torsten
    Misch, Daniel
    Roth, Andreas
    Boch, Christian
    Gruening, Wolfram
    Crolow, Catharina
    Griff, Sergej
    Mairinger, Thomas
    Bauer, Torsten T.
    EUROPEAN RESPIRATORY JOURNAL, 2012, 40
  • [28] ERCC1 expression by immunohistochemistry and EGFR mutations in resected non-small cell lung cancer
    Lee, K.
    Han, S.
    Min, H.
    Oh, D.
    Lee, S.
    Kim, D.
    Kim, Y.
    Kim, T.
    Heo, D.
    Bang, Y.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [29] ERCC1 Is a Predictive Biomarker for Non-small Cell Lung Cancer But Is Antibody-dependent
    Okimoto, Tamio
    Tsubata, Yukari
    Tanino, Ryosuke
    Nakao, Mika
    Hotta, Takamasa
    Hamaguchi, Megumi
    Hamaguchi, Shunichi
    Araki, Asuka
    Isobe, Takeshi
    ANTICANCER RESEARCH, 2021, 41 (05) : 2653 - 2660
  • [30] ERCC1 gene copy number variations in resected non-small cell lung cancer
    Friboulet, Luc
    Olaussen, Ken A.
    Valent, Alexander
    Tang, Ximing
    Tang, Tao
    Li, Yuanyuan
    Behrens, Carmen
    Vielh, Philippe
    Robin, Angelique
    Goubar, Aicha
    Validire, Pierre
    Wistuba, Ignacio
    Soria, Jean-Charles
    CANCER RESEARCH, 2012, 72
12345